Affordable Access

Publisher Website

Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response

Authors
Journal
Biological Psychiatry
0006-3223
Publisher
Elsevier
Publication Date
Volume
44
Issue
7
Identifiers
DOI: 10.1016/s0006-3223(97)00447-2
Keywords
  • Clomipramine
  • Intravenous
  • Adolescent
  • Depression
Disciplines
  • Medicine

Abstract

Abstract Background: Major depressive disorder (MDD) in the adolescent demonstrates a unique clinical profile, and pathogenic serotonergic dysregulation is hypothesized. Parenteral clomipramine (CMI) is known to distinguish adult MDD from control, but neurochallenge data are lacking in adolescent MDD. Methods: Thirteen drug-free outpatient adolescents who met DSM-III-R criteria for MDD were compared to adolescent controls by acute neuroendocrine and mood response to 12.5 mg of parenteral CMI. Results: Repeated measures analysis revealed significant changes from baseline for sadness ( p < .01) between groups, with normal controls increasing sadness rating after CMI. Prolactin (PRL) maximum change score from baseline was decreased in MDD relative to controls ( p < .05). Gender effects on PRL were evident in controls but not in MDD. Conclusions: The findings of PRL blunting in adolescent MDD mirrors previous work in adults. A unique finding is the induction of sadness in normal adolescent controls after CMI infusion.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments